Amy Elazzouzi
Net worth: 1 M $ as of 2026-07-30
Net worth: 1 M $ as of 2026-07-30
Amy Elazzouzi is currently Director-Finance & Operations at Kew, Inc. and Secretary, Treasurer & Chief Accounting Officer at Aura Biosciences, Inc. Formerly, Ms. Elazzouzi was Controller at AVEO Pharmaceuticals, Inc. Education includes an MBA from Northeastern University and an undergraduate degree from Regis College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0.14% | 2026-08-31 | 143,600 ( 0.14% ) | 1 M $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| AURA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 2024-10-24 |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Director of Finance/CFO | - |
| Companies | Position | End |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regis College
Regis College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
Select your edition
All financial news and data tailored to specific country editions